Related Experiment Video
Updated: Apr 12, 2026
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Ocriplasmin for foveal schisis in X-linked retinoschisis
1Department of Ophthalmology, University of California, Davis, Sacramento, California.
Purpose:
To report a case of foveal schisis in X-linked retinoschisis treated with ocriplasmin.
Methods:
Case report.
Results:
A 27-year-old man with X-linked retinoschisis was treated with a single intravitreal injection of ocriplasmin. After injection, a posterior vitreous detachment was induced and the macular schisis cavity resolved at 1 week. Central macular thickness on optical coherence tomography decreased from 731 μm to 185 μm, visual acuity remained unchanged, and there were no adverse events. However, the macular schisis cavity recurred at 1 month.
Conclusion:
This is the first reported case of using ocriplasmin to treat foveal schisis in X-linked retinoschisis. Although vitreomacular traction was relieved, the schisis cavity recurred shortly after initial closure.
